Virpax Pharmaceuticals Inc. (NASDAQ:VRPX) went up by 1.00% from its latest closing price compared to the recent 1-year high of $8.24. The company’s stock price has collected 7.95% of gains in the last five trading sessions. Press Release reported on 06/02/21 that Virpax Pharmaceuticals to Present at LD Micro Invitational XI Event on Wednesday, June 9(th) at 4:30 PM ET
Is It Worth Investing in Virpax Pharmaceuticals Inc. (NASDAQ :VRPX) Right Now?
Opinions of the stock are interesting as 0 analysts out of 0 who provided ratings for Virpax Pharmaceuticals Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
VRPX currently public float of 2.06M and currently shorts hold a 1.86% ratio of that float. Today, the average trading volume of VRPX was 171.31K shares.
VRPX’s Market Performance
VRPX stocks went up by 7.95% for the week, with a monthly jump of 19.35% and a quarterly performance of -5.75%. The volatility ratio for the week stands at 19.47% while the volatility levels for the past 30 days are set at 11.30% for Virpax Pharmaceuticals Inc.. The simple moving average for the period of the last 20 days is 10.06% for VRPX stocks with a simple moving average of -0.09% for the last 200 days.
VRPX Trading at 8.64% from the 50-Day Moving Average
After a stumble in the market that brought VRPX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -42.35% of loss for the given period.
Volatility was left at 11.30%, however, over the last 30 days, the volatility rate increased by 19.47%, as shares surge +20.25% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.04% lower at present.
During the last 5 trading sessions, VRPX rose by +7.95%, in comparison to the 20-day moving average, which settled at $4.36. In addition, Virpax Pharmaceuticals Inc. saw -27.26% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at VRPX starting from Jambulingam Thani, who purchase 100 shares at the price of $7.16 back on Feb 17. After this action, Jambulingam Thani now owns 100 shares of Virpax Pharmaceuticals Inc., valued at $716 using the latest closing price.
Stock Fundamentals for VRPX
The liquidity ratio also appears to be rather interesting for investors as it stands at 0.02.